2B or Not 2B? That Was the Question for Aspartame In our recent Carrier Management article, titled “2B or Not 2B? That Was the Question for Aspartame,” we delve into…
read morePraedicat Posts on News Article
KBW released a report on the webinar they held recently with our own Robert Reville and Adam Grossman. It featured a great discussion on the challenges PFAS poses to casualty…
read moreMonte Carlo 2023 Coverage September 11, 2023: In the face of rising litigation, how is the industry managing liability exposure to per- and polyfluoroalkyl substances (PFAS)? That is the question…
read moreAugust 30, 2023: D&O Underwriters May Be Worried About the Wrong Greenhouse Gas Greenwashing lawsuits with respect to climate change, while still relatively uncommon, have seen an uptick in recent…
read moreJuly 2023 – The PFAS investment opportunity PFAS may very well be the next asbestos. But PFAS may also be the next big investment opportunity. If you are skeptical, we…
read moreJune 8, 2023: Endocrine Disruption Litigation Has Arrived In their latest article for Carrier Management, Praedicat’s David Loughran and Adam Grossman explore the emergence of endocrine disruption as a major…
read moreMarch 9th, 2022: Casualty Underwriting: The Original ESG In their latest article with Carrier Management, David Loughran and Robert Reville examine a topic that is top of mind for investors,…
read moreNovember 24th, 2021: What Do You Do With Emerging Interest Risks? What’s interesting to scientists should always be of interest to liability insurers. That’s the message our own Dr. Adam…
read moreAugust 24th, 2021: PFAS Litigation Levels Already at Epic Proportions PFAS litigation has reached epic proportions. Praedicat recently completed a massive data collection for our PFAS Litigation Tracker, a tool…
read moreMay 2021 – Climate change is here and so is climate-related litigation. But what does climate change have to do with the recent lawsuits filed against baby food manufacturers? As…
read moreMay 25th, 2021: Opioids Are the Next Tobacco. Are Antibiotics the Next Opioids? In our most recent Carrier Management article, Praedicat’s Senior Scientist and VP of Modeling, Dr. Adam Grossman and…
read moreApril 2021 – Per- and polyfluoroalkyl substances (PFAS) is a Litagion© Praedicat has been monitoring through our Emerging Risk lifecycle for some time. In an AM Best article, “On High…
read more